243 related articles for article (PubMed ID: 22568880)
1. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
3. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
5. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
6. Giant mature ovarian cystic teratoma including more than 300 teeth.
Devoize L; Collangettes D; Le Bouëdec G; Mishellany F; Orliaguet T; Dallel R; Baudet-Pommel M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):e76-9. PubMed ID: 18280952
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers in mature cystic teratomas of the ovary.
Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of CA19-9 and CA125 in histological subtypes of epithelial ovarian tumors and ovarian endometriosis.
Nakagawa N; Koda H; Nitta N; Nakahara Y; Uno J; Hashimoto T; Nakahori T; Hasegawa M; Kataoka M
Acta Med Okayama; 2015; 69(4):227-35. PubMed ID: 26289914
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
Toki T; Kubota J; Lu X; Nakayama K
Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
14. Relevance of frozen sections and serum markers in invasive squamous cell carcinoma arising from ovarian mature cystic teratoma: two case reports.
Tazo Y; Yoshimura Y; Shoda T; Kyushima N; Okada T; Yamazaki H
J Med Case Rep; 2016 Jan; 10():20. PubMed ID: 26801904
[TBL] [Abstract][Full Text] [Related]
15. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
16. Detection of ovarian cancer by determination of CA 125 in different patohistologycal types of tumor according to age.
Vranes HS; Klarić P; Kuna K; Kraljević Z; Gall V; Jukić M
Coll Antropol; 2012 Jun; 36(2):425-9. PubMed ID: 22856226
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
18. Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
Nanki Y; Chiyoda T; Kataoka F; Nomura H; Nakadaira N; Iwasa N; Hashimoto S; Arima H; Susumu N; Aoki D
J Obstet Gynaecol Res; 2017 Apr; 43(4):744-748. PubMed ID: 28370831
[TBL] [Abstract][Full Text] [Related]
19. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
20. Ovarian vein vs peripheral blood CA125 serum levels: a comparative study.
Podnos YD; Gamboa G; Kurosaki T; Buller R; Walker JL; Manetta A
Gynecol Oncol; 1997 Jul; 66(1):71-4. PubMed ID: 9234924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
